SCHEMBL414404

SCHEMBL414404

Fc1ccc(S)c(F)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29628503 1.00
Potassium SCHEMBL9426450 0.97 ALDH1A1 (0.46)
SCHEMBL9426445 0.97 ALDH1A1 (0.46)
SCHEMBL23699530 0.79
SCHEMBL30696168 0.77
SCHEMBL1967994 0.77
SCHEMBL425322 0.77
SCHEMBL4768705 0.74
SCHEMBL6519928 0.74 CA3 (0.46)
SCHEMBL6517476 0.74 CA3 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 753 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4004955-B1 FERROFLUID SYSTEM CONTAINING GOLD PARTICLES RICHEMONT INT SA (CH) 2026-04-22 EP claimed
EP-3547414-B1 LITHIUM ELECTRODE AND LITHIUM SECONDARY BATTERY COMPRISING SAME LG ENERGY SOLUTION LTD (KR) 2023-09-13 EP claimed
EP-3664213-B1 ELECTROLYTE FOR LITHIUM METAL BATTERY AND LITHIUM METAL BATTERY COMPRISING SAME LG ENERGY SOLUTION LTD (KR) 2023-09-13 EP claimed
US-11495824-B2 Electrolyte for lithium metal battery and lithium metal battery comprising same LG ENERGY SOLUTION, LTD. (KR) 2022-11-08 US claimed
CN-110192294-B Lithium electrode and lithium secondary battery comprising same 株式会社LG新能源 2022-09-20 CN claimed
CN-111033864-B Electrolyte for lithium metal battery and lithium metal battery comprising same 株式会社LG新能源 2022-08-12 CN claimed
EP-4004955-A1 FERROFLUID SYSTEM CONTAINING GOLD PARTICLES Cartier International AG (CH) 2022-06-01 EP claimed
CN-110452204-B Xanthatin thioether and imine derivatives, and preparation method and application thereof 山西农业大学 2021-03-12 CN claimed
EP-3770927-A1 FERROFLUID SYSTEM CONTAINING GOLD PARTICLES Cartier International AG (CH) 2021-01-27 EP claimed
US-20200273629-A1 LIGAND MODIFIED PEROVSKITE OPTOELECTRONIC DEVICES THE UNIVERSITY OF HONG KONG (CN) 2020-08-27 US claimed
WO-2007006544-A2 CYCLIC ADENOSINE MONOPHOSPHATE COMPOUNDS FOR THE TREATMENT OF IMMUNE-RELATED DISORDERS VRIJE UNIVERSITEIT BRUSSEL (BE) 2007-01-18 WO claimed
US-20060100166-A1 Compounds for modulating the activity of exchange proteins directly activated by camp (epacs) KYLIX B.V. (NL) 2006-05-11 US claimed
EP-1066269-B1 TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS JANSSEN PHARMACEUTICA NV (BE) 2005-05-11 EP claimed
EP-1511757-A1 NEW COMPOUNDS FOR MODULATING THE ACTIVITY OF EXCHANGE PROTEINS DIRECTLY ACTIVATED BY CAMP (EPACS) Kylix B.V. (NL) 2005-03-09 EP claimed
WO-2003104250-A1 NEW COMPOUNDS FOR MODULATING THE ACTIVITY OF EXCHANGE PROTEINS DIRECTLY ACTIVATED BY CAMP (EPACS) KYLIX, B. V. (NL) 2003-12-18 WO claimed
US-20020115668-A1 Trisubstituted 1,3,5-triazine derivatives DAEYAERT FREDERIK FRANS DESIRE (BE) 2002-08-22 US claimed
EP-1066269-A1 TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS JANSSEN PHARMACEUTICA N.V. (BE) 2001-01-10 EP claimed
US-6150360-A ADMINISTERING TO A PATIENT SUFFERING FROM HUMAN IMMUNODEFICIENCY VIRUS INFECTION A TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVE JANSSEN PHARMACEUTICA N.V. (BE) 2000-11-21 US claimed
CN-1234792-A Nitrate ester derivatives and their use in the treatment of urinary incontinence and other disorders NICOX SA (FR) 1999-11-10 CN claimed
WO-1999050256-A1 TRISUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR TREATMENT OF HIV INFECTIONS JANSSEN PHARMACEUTICA N.V. (BE) 1999-10-07 WO claimed